Transcriptional analysis of hENT1 by RT-PCR in 102 laser micro-dissected pancreatic cancer specimens demonstrated a three-fold improvement in median overall survival, from 8.5 to 25.7 months, in tumors with higher versus lower levels of hENT1 expression [37]. The gene discussed is SLC29A1; the disease is familial pancreatic carcinoma.